Appointment New Patient Appointment or 214-645-8300

MedBlog

Search Results

Results: Articles

Cancer; Women's Health

PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients

PARP-1 inhibitor drugs can reduce the risk of BRCA- and HRDS-associated ovarian cancer by 70%. New research at UT Southwestern Medical Center may help expand treatment to more patients.

Cancer; Discovery; Prevention

Precision medicine, immunotherapy drive largest single-year drop in cancer deaths

Cancer death rates have dropped nearly 30% since 1991, and more that 2% between 2016 and 2017 alone – the biggest one-year drop on record. The driver has been precision medicine, an approach that focuses on personalization and collaboration. Learn more now.

Cancer

‘My dog saved my life’: How Madelyn has survived ovarian cancer for 10 years

UT Southwestern patient, Madelyn, shares how her dog prompted her to see the doctor that diagnosed her with ovarian cancer.